Salmonellosis future or investigational therapies: Difference between revisions
Joao Silva (talk | contribs) No edit summary |
Joao Silva (talk | contribs) No edit summary |
||
| Line 4: | Line 4: | ||
==Overview== | ==Overview== | ||
Recently the different genotypes of salmonella were associated with the different manifestations of the disease, yet, the process is not fully understood. Future studies are required to explain if there is a genetic basis for invasive non-Typhoidal Salmonella, and why certain non-typhoidal salmonella strains cause more severe disease than others. | |||
==References== | ==References== | ||
Revision as of 23:06, 20 August 2014
|
Salmonellosis Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Salmonellosis future or investigational therapies On the Web |
|
American Roentgen Ray Society Images of Salmonellosis future or investigational therapies |
|
Salmonellosis future or investigational therapies in the news |
|
Risk calculators and risk factors for Salmonellosis future or investigational therapies |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: João André Alves Silva, M.D. [2] Jolanta Marszalek, M.D. [3]
Overview
Recently the different genotypes of salmonella were associated with the different manifestations of the disease, yet, the process is not fully understood. Future studies are required to explain if there is a genetic basis for invasive non-Typhoidal Salmonella, and why certain non-typhoidal salmonella strains cause more severe disease than others.